Closed
SectorHealthcare
26.35 4.48
24h
Min
24.28
Max
26.79
Income | -8.3M -71M |
---|---|
Sales | 3.7M 7.4M |
EPS | -0.89 |
Profit margin | -956.884 |
Employees | 188 |
EBITDA | -8.3M -69M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +114.94% upside |
Next Earnings | 2 maj 2025 |
---|
Market Cap | -363M 1.9B |
---|---|
Previous open | 21.87 |
Previous close | 26.35 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 58.83 USD 114.94%
High 97 USD
Low 49 USD
Based on 14 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$